Bone marrow and serum connective tissue polypeptides in idiopathic myelofibrosis
- 28 June 2008
- journal article
- Published by Wiley in Clinical and Laboratory Haematology
- Vol. 17 (1) , 35-39
- https://doi.org/10.1111/j.1365-2257.1995.tb00314.x
Abstract
The distribution of collagen type VI and tenascin has been determined in both normal and myelofibrotic bone marrow by immunohistological techniques. In normal sections positivity was demonstrated in the periosteum (collagen type VI and tenascin) and in the walls of small blood vessels (tenascin). In contrast, myelofibrotic bone marrow showed an increased deposition of both proteins, especially collagen type VI, although this increase was restricted to the later fibrotic stages of the disease. Serum concentrations of collagen type I (PICP), collagen type III (PIIIP) and laminin (laminin P1) related polypeptides were determined in a further 26 patients. PIIIP levels were significantly raised, in contrast to PICP and laminin P1 concentrations. All three markers, however, were significantly elevated in patients with active/transforming disease. Laminin P1 and PICP levels showed a strong correlation, indicating a relationship between basement membrane and interstitial collagen metabolism, although they do not appear to offer any advantage over PIIIP for the monitoring of disease activity.Keywords
This publication has 21 references indexed in Scilit:
- Pathogenesis of idiopathic myelofibrosis: role of growth factors.Journal of Clinical Pathology, 1992
- Distribution and cellular origin of collagen VI during development and in cirrhosisGastroenterology, 1992
- Increased intraplatelet levels of platelet‐derived growth factor and transforming growth factor‐β in patients with myelofibrosis with myeloid metaplasiaBritish Journal of Haematology, 1991
- Serum procollagen‐III‐peptide level correlates with disease activity in myelofibrosis with myeloid metaplasiaBritish Journal of Haematology, 1989
- New Collagens, New ConceptsAnnual Review of Cell Biology, 1988
- Type VI CollagenPublished by Elsevier ,1987
- Serum markers for type IV collagen and type III procollagen in the myelofibrosis‐osteomyelosclerosis syndrome and other chronic myeloproliferative disordersAmerican Journal of Hematology, 1986
- Immunohistochemical study of basement membrane proteins and type III procollagen in myelofibrosisBritish Journal of Haematology, 1986
- Immuno‐enzymatic detection of fibronectin in normal and pathological haematopoietic tissueBritish Journal of Haematology, 1985
- THE NATURAL HISTORY OF AGNOGENIC MYELOID METAPLASIA (AMM) AND A CRITICAL EVALUATION OF ITS RELATIONSHIP WITH THE MYELOPROLIFERATIVE SYNDROMEMedicine, 1971